The Blood and Marrow Transplant Program was established at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute in 1991 to provide stem cell transplants to patients with breast cancer. The program fell into a lull when transplant was proven ineffective for breast cancer, but about 10 years later it had a resurgence under the directorship of Michael Lill, MD, who joined the center in 1997. In 2002, the first allogeneic transplants were performed there. Now the program has grown to include 6 medical doctors and 6 nurse coordinators. An expected 140 transplants will be performed in 2012. The largest group of transplant patients is those with multiple myeloma, followed by those with lymphoma and leukemia.
To sign up for our newsletter or print publications, please enter your contact information below.
